Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Advanced Oncotherapy plc    AVO   GB00BD6SX109

ADVANCED ONCOTHERAPY PLC

(AVO)
  Report
Delayed Quote. Delayed London Stock Exchange - 11/27 11:35:29 am
30.5 GBX   --.--%
06/29ADVANCED ONCOTHERAPY : 2019 Annual Report
PU
02/20ADVANCED ONCOTHERAPY : UHB and AVO to collaborate over LIGHT system
PU
02/17ADVANCED ONCOTHERAPY : Purchase of a LIGHT proton therapy system
PU
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
30(c) 31(c) 31(c) 30.5(c) 30.5(c) Last
143 966 219 324 110 206 24 796 36 119 Volume
0.00% +3.33% 0.00% -1.61% 0.00% Change
More quotes
Financials
Sales 2020 11,8 M 15,7 M 15,7 M
Net income 2020 -22,5 M -29,9 M -29,9 M
Net Debt 2020 66,1 M 88,0 M 88,0 M
P/E ratio 2020 -3,36x
Yield 2020 -
Sales 2021 38,6 M 51,4 M 51,4 M
Net income 2021 -22,1 M -29,4 M -29,4 M
Net Debt 2021 91,9 M 122 M 122 M
P/E ratio 2021 -4,21x
Yield 2021 -
Capitalization 102 M 136 M 135 M
EV / Sales 2020 14,2x
EV / Sales 2021 5,01x
Nbr of Employees 129
Free-Float 41,2%
More Financials
Company
Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton... 
More about the company
All news about ADVANCED ONCOTHERAPY PLC
06/29ADVANCED ONCOTHERAPY : 2019 Annual Report
PU
02/20ADVANCED ONCOTHERAPY : UHB and AVO to collaborate over LIGHT system
PU
02/17ADVANCED ONCOTHERAPY : Purchase of a LIGHT proton therapy system
PU
02/11ADVANCED ONCOTHERAPY : Partnership with The London Clinic
PU
2019ADVANCED ONCOTHERAPY : Two-Year Collaborative Research Study
PU
2019ADVANCED ONCOTHERAPY : Subscription to raise c.GBP 2.7 million
PU
2019ADVANCED ONCOTHERAPY : Change of Broker
PU
2019ADVANCED ONCOTHERAPY : Further re funding for first LIGHT system
PU
2019ADVANCED ONCOTHERAPY : Exercise of Warrants and Issue of Equity
PU
More news
News in other languages on ADVANCED ONCOTHERAPY PLC

- No features available -

More news
Chart ADVANCED ONCOTHERAPY PLC
Duration : Period :
Advanced Oncotherapy plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADVANCED ONCOTHERAPY PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 135,00 GBX
Last Close Price 30,50 GBX
Spread / Highest target 343%
Spread / Average Target 343%
Spread / Lowest Target 343%
EPS Revisions
Managers
NameTitle
Nicolas Serandour Chief Executive Officer & Director
Michael Jeffrey Sinclair Executive Chairman
Ed Lee Chief Operating Officer
Graham Pughe Senior Vice President-Accounting & IT
Jonathan Farr Chief Clinical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ADVANCED ONCOTHERAPY PLC-23.75%136
CERNER CORPORATION0.97%22 718
PERKINELMER, INC.33.12%14 474
GN STORE NORD A/S60.04%10 378
BRUKER CORPORATION-0.61%7 756
LIFETECH SCIENTIFIC CORPORATION102.01%1 827